Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-04

Clinical Trial Update: The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial examining whether liraglutide affects glucose tolerance and risk of type 2 diabetes in women with prior gestational diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Tina Vilsboll | Conditions: Gestational Diabetes Mellitus | Phase 4 | Status: COMPLETED